Center For Financial Planning, Inc. Gilead Sciences, Inc. Transaction History
Center For Financial Planning, Inc.
- $781 Million
- Q1 2025
A detailed history of Center For Financial Planning, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 115 shares of GILD stock, worth $12,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115
Previous 138
16.67%
Holding current value
$12,470
Previous $12,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,285Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.45 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.92 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.81 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $136B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...